关于阿尔茨海默病在痴呆前诊断的考虑:一项系统综述

medRxiv - Medical Ethics Pub Date : 2021-09-22 DOI:10.1101/2021.09.16.21263690

Jetske van der Schaar, Leonie N.C. Visser, Femke H. Bouwman, Philip Scheltens, Annelien L. Bredenoord, Wiesje M. van der Flier

{"title":"关于阿尔茨海默病在痴呆前诊断的考虑:一项系统综述","authors":"Jetske van der Schaar, Leonie N.C. Visser, Femke H. Bouwman, Philip Scheltens, Annelien L. Bredenoord, Wiesje M. van der Flier","doi":"10.1101/2021.09.16.21263690","DOIUrl":null,"url":null,"abstract":"<strong>Introduction</strong> The NIA-AA research framework proposes a purely biological definition of Alzheimer’s Disease (AD). This implies AD can be diagnosed based on biomarker abnormalities. While this brings opportunities, it also raises challenges.","PeriodicalId":501154,"journal":{"name":"medRxiv - Medical Ethics","volume":"49 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Considerations regarding a diagnosis of Alzheimer’s Disease before dementia: a systematic review\",\"authors\":\"Jetske van der Schaar, Leonie N.C. Visser, Femke H. Bouwman, Philip Scheltens, Annelien L. Bredenoord, Wiesje M. van der Flier\",\"doi\":\"10.1101/2021.09.16.21263690\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<strong>Introduction</strong> The NIA-AA research framework proposes a purely biological definition of Alzheimer’s Disease (AD). This implies AD can be diagnosed based on biomarker abnormalities. While this brings opportunities, it also raises challenges.\",\"PeriodicalId\":501154,\"journal\":{\"name\":\"medRxiv - Medical Ethics\",\"volume\":\"49 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-09-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"medRxiv - Medical Ethics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1101/2021.09.16.21263690\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"medRxiv - Medical Ethics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1101/2021.09.16.21263690","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

NIA-AA研究框架提出了阿尔茨海默病(AD)的纯生物学定义。这意味着AD可以根据生物标志物异常进行诊断。这在带来机遇的同时，也带来了挑战。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Considerations regarding a diagnosis of Alzheimer’s Disease before dementia: a systematic review

Introduction The NIA-AA research framework proposes a purely biological definition of Alzheimer’s Disease (AD). This implies AD can be diagnosed based on biomarker abnormalities. While this brings opportunities, it also raises challenges.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

medRxiv - Medical Ethics

自引率

0.00%

发文量